1. Home
  2. Analysis
  3. Ribavirin
  4. Stribild

Ribavirin and Stribild drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribavirin (ribavirin) and Stribild (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate). Common drug interactions include jc virus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Ribavirin and Stribild. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.

What is Stribild?

Stribild has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 16,425 Stribild users. Check the latest studies of Stribild.

On Aug, 05, 2026

18 people who take Ribavirin and Stribild together, and have interactions are studied.

Ribavirin and Stribild drug interactions.

What are the common drug interactions of Ribavirin and Stribild, by gender? *:

female:

n/a

male:

  1. Jc virus infection
  2. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  3. Emotional disorder
  4. Nausea (feeling of having an urge to vomit)
  5. Anaemia (lack of blood)
  6. Arrhythmia (irregular heartbeat)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  9. Anger
  10. Coma hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma)

What are the common drug interactions of Ribavirin and Stribild, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Jc virus infection
  2. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

50-59:

  1. Anaemia (lack of blood)
  2. Arrhythmia (irregular heartbeat)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  5. Coma hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma)
  6. Drug ineffective

60+:

  1. Anger
  2. Depressed mood
  3. Emotional disorder
  4. Nausea (feeling of having an urge to vomit)

* Approximation only. Some reports may have incomplete information.

Do you take Ribavirin and Stribild?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribavirin and Stribild:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Stribild:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stribild and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Ribavirin and Stribild, respectively), and Ribavirin and Stribild (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.